October 24, 2022

Read about NervGen and its research in Alzheimer’s in this article in Health Europa

July 29, 2022

Read about NervGen and our preclinical results in stroke in this article in BioSpace 

July 28, 2022

New Scientist’s Carissa Wong writes about NervGen’s potential in stroke following Cell Reports publication

July 18, 2022

Article in Contract Pharma by NervGen President & CEO, Paul Brennan, on the role of Biotech in improving Stroke outcomes.


April 16, 2021

BioProcess International

BioProcess International features a byline from Paul Brennan.